Welcome to this week’s issue of The Dose. The cannabis and psychedelics industries are ramping up for the fall conference season. Meanwhile, the events announced at some of last spring’s events are still unfolding — including one of the biggest pledges ever to psychedelics science. Blake Mycoskie, the founder of Toms Shoes, announced earlier this … Read more
For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin. Cisplatin causes the death of quick-dividing tumour cells, so it is a potent first-line defence in the treatment of the often fatal disease. However, over half of ovarian cancer patients develop recurrence and … Read more
It’s been a busy year-and-a-half for the cannabis industry, especially in New Mexico.Next year, business owners predict “you’re probably going to see five or $600 million a year sales range,” Priscotty Cannabis Delivery CEO Scott Prisco said.More than $350 million have been generated since it’s recreational use has been legalized. Now, the Department of Health … Read more
A recent Environmental Health Perspectives study compares the levels of metal biomarkers in the blood and urine of marijuana users with non-users. Study: Blood and Urinary Metal Levels among Exclusive Marijuana Users in NHANES (2005–2018). Image Credit: Inside Creative House / Shutterstock.com Background Marijuana is one of the most commonly used drugs throughout the world. Although many … Read more
01 September 2023 Goodwin Procter LLP To print this article, all you need is to be registered or login on Mondaq.com. HHS has announced the ten drugs that will be included in the first year of the Inflation Reduction Act’s new Drug Price Negotiation Program. They are: Eliquis (apixaban, Bristol Myers Squibb) Jardiance (empagliflozin, Boehringer … Read more
US health officials are recommending easing restrictions on marijuana, a move that sets the stage for potentially expanding the cannabis market across the country. A top official at the Department of Health and Human Services wrote Drug Enforcement Agency Administrator Anne Milgram calling for marijuana to be reclassified as a Schedule III drug under the … Read more
Welcome to my weekly newsletter on the cannabis and psychedelics industries. Analysts and investors are always looking for “catalysts” that can boost stocks. And in the psychedelics space, with biotech-style companies researching pharmaceutical drug candidates, such events can be massive gamechangers. Recent funding rounds for companies in the psychedelics space are renewing interest in their … Read more
In a recent study published in the Nutrients Journal, researchers summarized the evidence on ketogenic diets (KDs) from the past three decades. Study: The Influence of Ketogenic Diet on Gut Microbiota: Potential Benefits, Risks and Indications. Image Credit: Boontoom Sae-Kor/Shutterstock.com Background KD is characterized by minimal intake of carbohydrates, low calories, standard protein levels, and high fat … Read more
With the advent of ChatGPT4, the use of artificial intelligence in medicine has absorbed the public’s attention, dominated news headlines, and sparked vigorous debates about the promise and peril of medical AI. But the potential of AI reaches far beyond the frontlines of medicine. AI is already changing the way scientists discover and design drugs. … Read more
There’s a new class of weight-loss drugs in town. GLP-1 medications including Ozempic, Wegovy and Mounjaro were created to treat diabetes but have since been found to suppress appetites and induce substantial weight loss. It’s a big deal for the companies which make them, with shares of Novo Nordisk and Eli Lilly all soaring in … Read more